202 related articles for article (PubMed ID: 23402902)
1. Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement.
Diver E; O'Connor O; Garrett L; Boruta D; Goodman A; Del Carmen M; Schorge J; Mueller P; Growdon W
Gynecol Oncol; 2013 May; 129(2):332-5. PubMed ID: 23402902
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.
Pothuri B; Montemarano M; Gerardi M; Shike M; Ben-Porat L; Sabbatini P; Barakat RR
Gynecol Oncol; 2005 Feb; 96(2):330-4. PubMed ID: 15661217
[TBL] [Abstract][Full Text] [Related]
3. Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical intervention.
Perri T; Korach J; Ben-Baruch G; Jakobson-Setton A; Ben-David Hogen L; Kalfon S; Beiner M; Helpman L; Rosin D
Eur J Surg Oncol; 2014 Jul; 40(7):899-904. PubMed ID: 24268761
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction.
Abu-Rustum NR; Barakat RR; Venkatraman E; Spriggs D
Gynecol Oncol; 1997 Mar; 64(3):493-5. PubMed ID: 9062158
[TBL] [Abstract][Full Text] [Related]
5. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series.
Caceres A; Zhou Q; Iasonos A; Gerdes H; Chi DS; Barakat RR
Gynecol Oncol; 2008 Mar; 108(3):482-5. PubMed ID: 18190953
[TBL] [Abstract][Full Text] [Related]
6. Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy.
Campagnutta E; Cannizzaro R; Gallo A; Zarrelli A; Valentini M; De Cicco M; Scarabelli C
Gynecol Oncol; 1996 Jul; 62(1):103-5. PubMed ID: 8690280
[TBL] [Abstract][Full Text] [Related]
7. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients.
Brard L; Weitzen S; Strubel-Lagan SL; Swamy N; Gordinier ME; Moore RG; Granai CO
Gynecol Oncol; 2006 Oct; 103(1):176-80. PubMed ID: 16564074
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of small bowel obstruction in patients with previous gynecologic malignancies.
Mirensky TL; Schuster KM; Ali UA; Reddy V; Schwartz PE; Longo WE
Am J Surg; 2012 Apr; 203(4):472-9. PubMed ID: 22172316
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
Chen AM; Li BQ; Lau DH; Farwell DG; Luu Q; Stuart K; Newman K; Purdy JA; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1026-32. PubMed ID: 20231073
[TBL] [Abstract][Full Text] [Related]
10. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.
Pothuri B; Meyer L; Gerardi M; Barakat RR; Chi DS
Gynecol Oncol; 2004 Oct; 95(1):193-5. PubMed ID: 15385131
[TBL] [Abstract][Full Text] [Related]
11. Effects of percutaneous endoscopic gastrostomy tube placement on gastric antral motility and gastric emptying.
Ono H; Azuma T; Miyaji H; Ito S; Ohtaki H; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
J Gastroenterol; 2003; 38(10):930-6. PubMed ID: 14614599
[TBL] [Abstract][Full Text] [Related]
12. Uncovered self-expandable metallic stent placement as a first-line palliative therapy in unresectable malignant duodenal obstruction.
Ahn HS; Hong SJ; Moon JH; Ko BM; Choi HJ; Han JP; Park JS; Kang MS; Cho JY; Lee JS; Lee MS
J Dig Dis; 2012 Dec; 13(12):628-33. PubMed ID: 23134154
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL
Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231
[TBL] [Abstract][Full Text] [Related]
14. The outcome after stent placement or surgery as the initial treatment for obstructive primary tumor in patients with stage IV colon cancer.
Lee WS; Baek JH; Kang JM; Choi S; Kwon KA
Am J Surg; 2012 Jun; 203(6):715-9. PubMed ID: 22265203
[TBL] [Abstract][Full Text] [Related]
15. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
16. A pre-post retrospective study of patients with cystic fibrosis and gastrostomy tubes.
Best C; Brearley A; Gaillard P; Regelmann W; Billings J; Dunitz J; Phillips J; Holme B; Schwarzenberg SJ
J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):453-8. PubMed ID: 21613963
[TBL] [Abstract][Full Text] [Related]
17. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience.
Hoda D; Jatoi A; Burnes J; Loprinzi C; Kelly D
Cancer; 2005 Feb; 103(4):863-8. PubMed ID: 15641035
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction.
Chouhan J; Gupta R; Ensor J; Raghav K; Fogelman D; Wolff RA; Fisch M; Overman MJ
Cancer Med; 2016 Feb; 5(2):239-47. PubMed ID: 26714799
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous endoscopic drainage gastrostomy in the treatment of gastrointestinal obstruction from intraperitoneal malignancy.
Adelson MD; Kasowitz MH
Obstet Gynecol; 1993 Mar; 81(3):467-71. PubMed ID: 7679789
[TBL] [Abstract][Full Text] [Related]
20. Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
Chan JK; Kapp DS; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Leiserowitz GS; Cress RD; O'Malley C
Obstet Gynecol; 2007 Jun; 109(6):1342-50. PubMed ID: 17540806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
